Analyst Price Targets — BWAY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 17, 2026 11:11 am | Raghuram Selvaraju | H.C. Wainwright | $14.00 | $14.84 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Brainsway (BWAY) |
| May 26, 2026 10:15 am | Raghuram Selvaraju | H.C. Wainwright | $17.00 | $15.10 | TheFly | Brainsway price target raised to $17 from $15 at H.C. Wainwright |
| January 26, 2026 11:07 am | — | H.C. Wainwright | $15.00 | $11.52 | TheFly | Brainsway price target raised to $30 from $24 at H.C. Wainwright |
| January 22, 2026 2:01 pm | — | Northland Securities | $15.00 | $12.30 | TheFly | Brainsway price target raised to $30 from $23 at Northland |
| December 8, 2025 11:15 am | Raghuram Selvaraju | H.C. Wainwright | $12.00 | $8.64 | TheFly | Brainsway price target raised to $24 from $18 at H.C. Wainwright |
| August 7, 2024 6:14 am | Raghuram Selvaraju | H.C. Wainwright | $8.00 | $3.45 | TheFly | Brainsway price target raised to $16 from $15 at H.C. Wainwright |
| May 9, 2024 7:36 am | Steven Lichtman | Oppenheimer | $5.50 | $2.85 | StreetInsider | Brainsway (BWAY) PT Raised to $11 at Oppenheimer |
| May 9, 2024 6:42 am | Raghuram Selvaraju | H.C. Wainwright | $7.50 | $2.85 | StreetInsider | Brainsway (BWAY) PT Raised to $15 at H.C. Wainwright |
| November 17, 2022 9:50 am | — | Northland Securities | $2.50 | $0.99 | Benzinga | Northland Capital Markets Maintains Outperform on BrainsWay, Lowers Price Target to $5 |
| August 22, 2022 6:21 am | — | H.C. Wainwright | $8.00 | $2.46 | Benzinga | HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $16 |
Latest News for BWAY
Investment further supports BrainsWay's strategy of partnering with growth-oriented mental health providers to raise awareness and expand access to transformative care Investment further supports BrainsWay's strategy of partnering with growth-oriented mental health providers to raise awareness and expand access to transformative care
BWAY, HTLD and NCNO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 14th, 2026.
HTLD, MEOH, NCNO, JD and BWAY have been added to the Zacks Rank #1 (Strong Buy) List on July 14th, 2026.
Nearly half of individuals diagnosed with PTSD also meet criteria for major depressive disorder (MDD), making comorbid depression one of the most common and clinically significant complications of PTSD
BURLINGTON, Mass. and JERUSALEM, June 22, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today announced further expansion in the number of medical policies across the U.S. providing favorable coverage for its SWIFT™ Accelerated Deep TMS™ protocol. The announcement comes after a series of favorable…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BWAY.
U.S. House Trading
No House trades found for BWAY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.